Total planned funding: $75,615,864
Allocations
Countries/Regions
| Central Asia Region | $75,615,864 |
Organizational Types
| Own Agency | $23,687,860 |
| Unknown | $19,115,035 |
| University | $11,950,700 |
| NGO | $8,739,169 |
| Host Country Government Agency | $6,477,871 |
| Private Contractor | $3,632,129 |
| Multi-lateral Agency | $1,665,000 |
| Other USG Agency | $181,100 |
| Implementing Agency | $167,000 |
Program Areas
| Prevention | $24,977,993 |
| Management and Operations | $16,419,860 |
| Governance and Systems | $15,544,500 |
| Care | $8,656,843 |
| Testing | $5,418,992 |
| Treatment | $4,597,676 |
Budget Codes
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $17,893,742 |
| HVMS: Management and Operations | $16,419,860 |
| HBHC: Care: Adult Care and Support | $7,229,602 |
| HLAB: Laboratory Infrastructure | $5,554,656 |
| HVCT: Testing: HIV Testing and Counseling | $5,418,992 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $5,204,146 |
| HVSI: Strategic Information | $5,124,283 |
| OHSS: Health Systems Strengthening | $4,865,561 |
| HTXS: Treatment: Adult Treatment | $4,564,507 |
| HVTB: Care: TB/HIV | $1,427,241 |
| HMBL: Biomedical Prevention: Blood Safety | $1,405,750 |
| HMIN: Biomedical Prevention: Injection Safety | $474,355 |
| HTXD: Treatment: ARV Drugs | $33,169 |
Top Partner Programs
Not Available:
$19,015,035
Countries/Regions
USG Aggregated Agencies:
$12,548,497
Countries/Regions
Central Asia Region
| 2011 | $5,099,999 |
| 2012 | $1,121,824 |
| 2015 | $4,926,674 |
| 2017 | $1,400,000 |
Columbia University:
$11,950,700
Countries/Regions
U.S. Centers for Disease Control and Prevention:
$6,221,704
Countries/Regions
Central Asia Region
| 2013 | $3,238,500 |
| 2014 | $2,983,204 |